Stephen rarely does public talks anymore. When he does, he draws an impressive crowd. And most of the people sitting in those seats are unaware of the effort that goes into composing the script he will follow over the course of the evening.
Today, a company is targeting Lou Gehrig's disease. Their approach is undergoing clinical trials in America, right now. But in Wisconsin, the home of stem cell research? If Republican lawmakers get their way, the research which might end Lou Gehrig's disease could be criminalized.